Carillon Tower Advisers’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$63.3M Buy
+382,676
New +$62.2M 0.39% 79
2020
Q3
Sell
-470,538
Closed -$64.5M 495
2020
Q2
$64.5M Hold
470,538
0.5% 61
2020
Q1
$52.7M Sell
470,538
-217,000
-32% -$28.6M 0.52% 49
2019
Q4
$91M Hold
687,538
0.61% 28
2019
Q3
$85.7M Buy
687,538
+21,209
+3% +$2.56M 0.6% 30
2019
Q2
$75.6M Buy
666,329
+35,251
+6% +$3.69M 0.52% 48
2019
Q1
$63.5M Hold
631,078
0.45% 59
2018
Q4
$54M Buy
631,078
+221,470
+54% +$19.9M 0.46% 60
2018
Q3
$37.5M Buy
409,608
+57,378
+16% +$5.09M 0.27% 151
2018
Q2
$30M Sell
352,230
-299,024
-46% -$25.2M 0.24% 152
2018
Q1
$52.9M Buy
651,254
+44,670
+7% +$3.52M 0.41% 70
2017
Q4
$43.7M Buy
+606,584
New +$41.7M 0.47% 64

Other funds holding ZTS

Carillon Tower Advisers's ZTS Position: Q4 2020 in Review

Carillon Tower Advisers opened a new position in Zoetis (ZTS) in Q4 2020: 382,676 shares worth $63.3M. The stake represents 0.39% of the portfolio and ranks #79 among its holdings. This is a return to the name: Carillon Tower Advisers previously reported a position in ZTS as recently as Q2 2020.

Carillon Tower Advisers first reported a position in ZTS in Q4 2017 and has held it in 12 quarters since. The position peaked at $91M in Q4 2019. 1,411 funds tracked by Wall St. Rank hold ZTS as of Q4 2020.

  • Carillon Tower Advisers held 382,676 shares of Zoetis worth $63.3M as of Q4 2020.
  • Zoetis was a new Carillon Tower Advisers position in Q4 2020.
  • Zoetis made up 0.39% of Carillon Tower Advisers's portfolio in Q4 2020, its #79 holding.
  • Carillon Tower Advisers first reported a position in Zoetis in Q4 2017 and has held it in 12 quarters since.
  • Carillon Tower Advisers's Zoetis position peaked at $91M in Q4 2019.
  • 1,411 funds tracked by Wall St. Rank held Zoetis as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.